Company profile for Vyome Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Vyome Therapeutics is an innovation-driven, clinical stage specialty pharmaceutical company, working to treat inflammatory diseases with locally-acting, next generation therapeutic solutions. Vyome's management team members are leaders in the drug development field, with deep expertise and a proven track record of successfully launching over 50 products in the life sciences and in building visionary companies. Vyome has ...
Vyome Therapeutics is an innovation-driven, clinical stage specialty pharmaceutical company, working to treat inflammatory diseases with locally-acting, next generation therapeutic solutions. Vyome's management team members are leaders in the drug development field, with deep expertise and a proven track record of successfully launching over 50 products in the life sciences and in building visionary companies. Vyome has a robust pipeline of novel locally-acting drug candidates designed to improve current standards of care for multifactorial diseases of unmet need which are underpinned by inflammation.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
100, Overlook Center, 2nd Floor, Princeton, New Jersey, 08540
Telephone
Telephone
+1 9738328147
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.businesswire.com/news/home/20251125558814/en/Vyome-Appoints-Renowned-Medical-Oncologist-Dr.-Aditya-Bardia-as-Senior-Medical-Advisor-to-Guide-the-Development-of-MFW-Program

BUSINESSWIRE
25 Nov 2025

https://www.businesswire.com/news/home/20251118862654/en/Vyome-Holdings-Announces-Transformational-First-Quarter-Following-Nasdaq-Listing

BUSINESSWIRE
18 Nov 2025

https://www.businesswire.com/news/home/20250917093826/en/Vyome-Presents-Strong-Data-Showing-Topical-VT-1908-is-an-Effective-Treatment-for-Uveitis-Opening-Up-a-%243B-Addressable-Market-Opportunity

BUSINESSWIRE
17 Sep 2025

https://www.businesswire.com/news/home/20250821234483/en/Vyome-Signs-MoU-with-Embryyo-Indias-Leading-Medical-Device-Innovation-Studio

BUSINESSWIRE
21 Aug 2025

https://www.businesswire.com/news/home/20250818462628/en/Vyome-Announces-Strategic-Review-of-Livechain-OTCID-LICH

BUSINESSWIRE
18 Aug 2025

https://www.businesswire.com/news/home/20250815679467/en/Vyome-To-Mark-First-Day-of-Trading-as-HIND-with-Nasdaq-Opening-Bell

BUSINESSWIRE
15 Aug 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty